RWA Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.99M | Sell |
7,598
-10,372
| -58% | -$5.45M | 0.05% | 179 |
|
|
2025
Q1 | $11.4M | Sell |
17,970
-456
| -2% | -$289K | 0.14% | 90 |
|
|
2024
Q4 | $13.1M | Buy |
18,426
+18,027
| +4,518% | +$12.8M | 0.16% | 85 |
|
|
2024
Q3 | $419K | Buy |
399
+2
| +0.5% | +$2.1K | 0.01% | 423 |
|
|
2024
Q2 | $417K | Hold |
397
| – | – | 0.01% | 411 |
|
|
2024
Q1 | $382K | Sell |
397
-30
| -7% | -$28.9K | 0.01% | 425 |
|
|
2023
Q4 | $375K | Buy |
+427
| New | +$375K | 0.01% | 412 |
|
|
2020
Q2 | – | Sell |
-998
| Closed | -$487K | – | 218 |
|
|
2020
Q1 | $487K | Sell |
998
-26
| -3% | -$12.7K | 0.07% | 134 |
|
|
2019
Q4 | $384K | Sell |
1,024
-15
| -1% | -$5.63K | 0.04% | 183 |
|
|
2019
Q3 | $288K | Sell |
1,039
-10
| -1% | -$2.77K | 0.03% | 201 |
|
|
2019
Q2 | $328K | Hold |
1,049
| – | – | 0.04% | 181 |
|
|
2019
Q1 | $431K | Sell |
1,049
-56
| -5% | -$23K | 0.05% | 166 |
|
|
2018
Q4 | $413K | Hold |
1,105
| – | – | 0.05% | 156 |
|
|
2018
Q3 | $446K | Hold |
1,105
| – | – | 0.05% | 154 |
|
|
2018
Q2 | $381K | Buy |
+1,105
| New | +$381K | 0.04% | 174 |
|